Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safe and tolerable dose of axitinib given
together with cisplatin and capecitabine in patients with advanced gastric cancer who have
not received prior chemotherapy for their advanced cancer.